RankAlpha logo
Back to Rankings

CING

CingulateC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CING vs peer average
53/100
CING vs. peer average (C vs. C)
Grade spread
A 3 · B 2 · C 1 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

LTRN is the first available peer comparator.

Small-cap oncology/therapeutics developer with similar market cap and typical program-stage volatility—useful as an event-driven biotech comparator.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerLTRNLantern
CING
Cingulate
LTRN
Lantern
Grade
C
F
Momentum
12
27
Value
41
41
Sentiment
100
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs LTRN

CING / LTRN
Grade Position
In line
CING vs. peer average (C vs. C)
53/100
Momentum
12
LTRN
Value
41
CING
Sentiment
100
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CING
1
LTRN
LTRN
F
20/100
+2
2
DMRA
DMRA
C
60/100
Even
3
RNTX
RNTX
F
20/100
+2
4
TCRX
TScan Therapeutics Inc Common
F
20/100
+2
5
TELO
Telomir Pharmaceuticals Inc Common
F
20/100
+2
LTRN is the first peer returned for this comparison set.